Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer. Rubio-Cuesta B, Carretero-Puche C, Llamas P, Sarmentero J, et al. Br J Cancer 2025 Jun 6. doi: 10.1038/s41416-025-03058.

Read + Share

Amedeo Smart

Independent Medical Education

Rubio-Cuesta B, Carretero-Puche C, Llamas P, Sarmentero J, et al. Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer. Br J Cancer 2025 Jun 6. doi: 10.1038/s41416-025-03058.
PMID: 40481178